MegaRobo Technologies, a Suzhou-based company that builds AI infrastructure for physical systems, raised nearly US$200 million in new funding. Oman Investment Authority and CMB International joined the round. Existing backers Asia Investment Capital, Granite Asia, and Sinovation Ventures also participated.
Funding support
The financing will support continued investment in core technology. MegaRobo plans to expand its AI for Science business globally. It will also build infrastructure for AI operating in complex physical environments.
Company reach
MegaRobo has delivered products and technologies to more than 500 customers. These include pharmaceutical companies, biotechnology firms, and research institutions. Its Megalaxy Lab supports real-world experimentation for more than 200 customers.
What the platform does
One Intelligence Stack connects AI models, data, workflows, instruments, and robotics. The platform lets AI design experiments, run them in real laboratories, and learn from the results. MegaRobo applies this to drug discovery, covering early research through candidate optimization.
MegaRobo is expanding across North America, Europe, the Middle East, and Asia. Through Poreva Open, Megalaxy Lab will provide wet-lab validation for more than 10,000 protein design sequences. The company launched the challenge with Tencent Cloud and Twist Bioscience.